https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-15 / J. Immunol. 2006 May;176(10):6065-75
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-15 / J. Immunol. 2006 May;176(10):6065-752006-05-15 00:00:002019-02-15 08:37:40Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-15 / Int. J. Cancer 2006 May;118(10):2617-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-15 / Int. J. Cancer 2006 May;118(10):2617-272006-05-15 00:00:002019-02-15 09:19:52Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-52006-05-12 00:00:002019-02-15 08:44:40Virology- and immunology-based gene therapy for cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-05 / Cancer Gene Ther. 2006 Oct;13(10):905-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-05 / Cancer Gene Ther. 2006 Oct;13(10):905-182006-05-05 00:00:002019-02-15 09:19:46Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-22006-05-04 00:00:002024-12-03 08:04:16Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-312006-05-01 00:00:002006-05-01 00:00:00Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-252006-05-01 00:00:002006-05-01 00:00:00A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int J Hyperthermia 2006 May;22(3):229-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int J Hyperthermia 2006 May;22(3):229-342006-05-01 00:00:002019-02-15 08:35:29Cervical cancer: radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Rev Recent Clin Trials 2006 May;1(2):87-102
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Rev Recent Clin Trials 2006 May;1(2):87-1022006-05-01 00:00:002019-02-15 09:19:28Dendritic cell immunotherapy for melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Ai Zheng 2006 May;25(5):625-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Ai Zheng 2006 May;25(5):625-302006-05-01 00:00:002019-02-15 08:48:11[Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma–a report of ten cases]
